Rankings
▼
Calendar
EOLS FY 2024 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$353M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$266M
+31.8% YoY
Gross Profit
$182M
68.5% margin
Operating Income
-$34M
-12.9% margin
Net Income
-$50M
-18.9% margin
EPS (Diluted)
$-0.81
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$233M
Total Liabilities
$227M
Stockholders' Equity
$6M
Cash & Equivalents
$87M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$266M
$202M
+31.8%
Gross Profit
$182M
$141M
+29.7%
Operating Income
-$34M
-$49M
+30.1%
Net Income
-$50M
-$62M
+18.3%
← Q4 2023
All Quarters
Q1 2024 →